1 Prophylactic phenytoin (DPH) has been evaluated in 20 patients undergoing diagnostic myelography. DPH (0.75 g) was ingested at 20.00 h the night before and 0.5 g at 08.00 h on the morning of the procedure. 2 Total DPH concentrations at myelography (mean + s.d.: 12.7 + 4.3 mg 1-1; range 6.3-21.5 mg 1-1) correlated with CSF values (1.3 ± 0.46 mg 1-1; range 0.7-2.2 mg 1-1; r = 0.83, P < 0.001). 3 DPH protein binding at that time varied two-fold (9.2-18.5%) and free drug levels (1.7 + 0.6 mg 1-1) correlated with CSF (r = 0.83, P < 0.001) and total (r = 0.89, P < 0.001) plasma DPH concentrations. 4 There were significant negative correlations between patient weight (n = 17) and total (r = -0.57, P < 0.05) and CSF (r = -0.55, P < 0.05) DPH concentrations at myelography. 5 Total plasma DPH levels 8 h (14.5 ± 3.9 mg 1-1; range 7.3-20.6 mg [-l) and 24 h (12.3 + 3.8 mg 1-1; range 5.0-19.8 mg 1-1) after myelography were largely within the 'therapeutic range' of 10-20 mg 1-1 for the drug. 6 No patient suffered a seizure although, in two, spike discharges were seen on a postmyelography electroencephalogram. 7 A simple regime involving two doses of DPH would provide acceptable plasma CSF concentrations as a basis for controlled studies in seizure prophylaxis following neuroradiological investigations involving intrathecal contrast.